Related Experiment Video

Updated: Jun 28, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Topoisomerase I inhibitors and drug resistance

R E Parchment1, A Pessina

  • 1Division of Hematology-Oncology, The Barbara Ann Karmanos Cancer Institute, Wayne State University, 3900 John R., Detroit, MI, U.S.A.

Cytotechnology
|November 13, 2008
PubMed

Insights

DNA topoisomerase I is a key target for cancer drugs. Understanding drug resistance mechanisms is crucial for developing new therapies and improving chemotherapy effectiveness against tumors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • DNA topoisomerase I (Topoisomerase I) is a nuclear enzyme crucial for managing DNA topology.
  • Topoisomerase I is a validated target for cancer therapy, particularly with campthotecin-derived drugs.
  • Acquired resistance to chemotherapy poses a significant challenge in cancer treatment.

Purpose of the Study:

  • To elucidate the role of Topoisomerase I in cellular functions.
  • To review methods for assessing Topoisomerase I in vitro activity.
  • To discuss cytotoxicity mechanisms of Topoisomerase I inhibitors and drug resistance.

Main Methods:

  • Review of existing literature on Topoisomerase I function and activity assays.
  • Analysis of cytotoxicity mechanisms of campthotecin-class drugs.
  • Examination of molecular mechanisms underlying drug resistance.

Main Results:

  • Topoisomerase I's essential role in DNA replication, transcription, and repair is confirmed.
  • Campthotecin drugs exert cytotoxicity by stabilizing the Topoisomerase I-DNA cleavage complex.
  • Drug resistance can arise from various mechanisms, including alterations in drug target or cellular efflux pumps.

Conclusions:

  • Topoisomerase I remains a promising target for novel anticancer drug development.
  • Further research into drug resistance mechanisms is vital for overcoming therapeutic limitations.
  • Identifying factors that influence Topoisomerase I inhibitor efficacy will guide future therapeutic strategies.

More Related Videos

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples10:13

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples

Published on: December 2, 2022

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers06:02

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers

Published on: February 20, 2017

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
DNA Topoisomerases02:02

DNA Topoisomerases

Topoisomerases are enzymes that relax overwound DNA molecules during various cell processes, including DNA replication and transcription. These enzymes regulate positive and negative DNA supercoiling without changing the nucleotide sequence. DNA overwinding in a clockwise direction results in positively supercoiled DNA, whereas underwinding in a counterclockwise direction produces negatively supercoiled DNA.
Types and Mechanism of action
Topoisomerases are divided into two main types.  Type I...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...